1. Accelerating anticancer drug development — opportunities and trade-offs. Issue 12 (December 2018) Authors: Nass, Sharyl; Rothenberg, Mace; Pentz, Rebecca; Hricak, Hedvig; Abernethy, Amy; Anderson, Kenneth; Gee, Amanda; Harvey, R.; Piantadosi, Steven; Bertagnolli, Monica; Schrag, Deborah; Schilsky, Richard Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma. Issue 12 (December 2018) Authors: Samur, Mehmet; Minvielle, Stephane; Gulla, Annamaria; Fulciniti, Mariateresa; Cleynen, Alice; Aktas Samur, Anil; Szalat, Raphael; Shammas, Masood; Magrangeas, Florence; Tai, Yu-Tzu; Auclair, Daniel; Keats, Jonathan; Richardson, Paul; Attal, Michel; Moreau, Philippe; Anderson, Kenneth; Parmigiani,... Journal: Leukemia Issue: Volume 32:Issue 12(2018) Page Start: 2626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study. Issue 5 (May 2020) Authors: Richardson, Paul G; Bringhen, Sara; Voorhees, Peter; Plesner, Torben; Mellqvist, Ulf-Henrik; Reeves, Brandi; Paba-Prada, Claudia; Zubair, Hanan; Byrne, Catriona; Chauhan, Dharminder; Anderson, Kenneth; Nordström, Eva; Harmenberg, Johan; Palumbo, Antonio; Sonneveld, Pieter Journal: Lancet Issue: Volume 7:Issue 5(2020) Page Start: e395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ERYTHEMA NODOSUM. Issue 3177 (19th November 1921) Authors: Anderson, Kenneth; Cooper, Norman C. Journal: BMJ Issue: Volume 2:Issue 3177(1921) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma. (23rd October 2020) Authors: Dhakal, Binod; D'Souza, Anita; Callander, Natalie; Chhabra, Saurabh; Fraser, Raphael; Davila, Omar; Anderson, Kenneth; Assal, Amer; Badawy, Sherif M.; Berdeja, Jesus; Cerny, Jan; Comenzo, Raymond; Chakraborty, Rajshekhar; Peter Gale, Robert; Kamble, Rammurti; Kharfan‐Dabaja, Mohamed A.; Krem, Max... Journal: British journal of haematology Issue: Volume 191:Number 3(2020) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Crofton Cup II: non-tobacco sponsored golf goes full strength — players please. Issue 4 (April 1995) Authors: Anderson, Kenneth Journal: Thorax Issue: Volume 50:Issue 4(1995) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cancer Clinical Trials—Do We Need a New Algorithm in the Age of Stratified Medicine?. (22nd May 2013) Authors: Doroshow, James H.; Sleijfer, Stefan; Stupp, Roger; Anderson, Kenneth Journal: Oncologist Issue: Volume 18:Number 6(2013) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Issue 1 (December 2016) Authors: Boyiadzis, Michael; Bishop, Michael; Abonour, Rafat; Anderson, Kenneth; Ansell, Stephen; Avigan, David; Barbarotta, Lisa; Barrett, Austin; Van Besien, Koen; Bergsagel, P.; Borrello, Ivan; Brody, Joshua; Brufsky, Jill; Cairo, Mitchell; Chari, Ajai; Cohen, Adam; Cortes, Jorge; Forman, Stephen; Frie... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth. (5th July 2017) Authors: Dimopoulos, Meletios A.; Lonial, Sagar; White, Darrell; Moreau, Philippe; Palumbo, Antonio; San‐Miguel, Jesus; Shpilberg, Ofer; Anderson, Kenneth; Grosicki, Sebastian; Spicka, Ivan; Walter‐Croneck, Adam; Magen, Hila; Mateos, Maria‐Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Bleickardt, ... Journal: British journal of haematology Issue: Volume 178:Number 6(2017) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MUC1‐C is a target in lenalidomide resistant multiple myeloma. (23rd June 2017) Authors: Yin, Li; Tagde, Ashujit; Gali, Reddy; Tai, Yu‐Tzu; Hideshima, Teru; Anderson, Kenneth; Avigan, David; Kufe, Donald Journal: British journal of haematology Issue: Volume 178:Number 6(2017) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗